在结直肠癌中实施免疫评分:从队列研究中吸取教训,限制和采用障碍的障碍
Matthew Ss Hsu1,2, Suet Yi Leung1,2,3
1Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
The journal of pathology. Clinical research
|December 29, 2025
概括
免疫评分 (IS) 是结直肠癌 (CRC) 的一个强大的工具,可以预测患者的结果和对化疗和免疫疗法的反应. 进一步的研究旨在克服更广泛的临床使用的局限性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 免疫评分 (IS) 评估结直肠癌 (CRC) 瘤中的T细胞密度,在预后方面表现优于TNM分期和MMR状态.
- 国际上已经验证了IS用于预测III期结肠癌中辅助化疗的益处.
- 免疫评分-IC是一种精细的版本,可以识别转移性CRC患者从免疫检查点抑制剂中受益.
研究的目的:
- 审查结直肠癌 (CRC) 中免疫评分 (IS) 的演变和验证.
- 突出IS的化学疗法和免疫疗法的预后和预测能力.
- 讨论IS在CRC病理学中的更广泛临床采用的挑战和机会.
主要方法:
- 审查具有里程碑意义的Immunoscore (IS) 出版物和国际验证队列.
- 整合了辅助剂试验和对CRC中免疫检查点抑制剂的研究结果.
- 对影响IS临床实用性的技术和生物因素的分析.
主要成果:
- 与传统标志物相比,IS在结直肠癌 (CRC) 中表现出优异的预后性能.
- 在第三阶段结肠癌中,IS预测辅助化疗对结肠癌有益.
- 免疫评分-IC识别了对免疫检查点抑制剂有反应的转移性CRC患者的一个子集.
结论:
- 免疫评分 (IS) 是结直肠癌 (CRC) 的一个强大的预后和预测生物标志物.
- 证据支持IS在指导化疗和免疫治疗决策中的作用.
- 解决目前的局限性可以促进IS在CRC管理中的更广泛的临床整合.
更多相关视频
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
9.7K
15:17Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
14.3K
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:21Cancer Survival Analysis
626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
01:30Cancer Vaccines
926
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
02:59Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K